Cingulate joins Russell 3000E Index; CMO trial period extended to Sept 30

Cingulate Inc.

Added to Russell 3000E Index, effective after June 2026 reconstitution; semi-annual reconstitution begins Dec 2026.
CEO Shane Schaffer says inclusion enhances visibility with institutional investors and supports long-term growth.
Employment agreement amendment extends CMO Matthew N. Brams' trial period from June 30 to September 30, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.